Proficiency Testing Program List
*New Program(s) Available for Domestic and International Laboratories in Q1 2026
'New Program(s) Available for Domestic Laboratories in Q1 2026
| Proficiency Testing Programs | Analyte(s) Included |
|---|---|
| Acylcarnitines (ACPT) | Low Free Carnitine (C0(L)), High Free Carnitine (C0(H)), Low Acetylcarnitine (C2(L)), Propionylcarnitine (C3), Malonylcarnitine [derivatized] (C3DC), Malonylcarnitine + Hydroxybutyrylcarnitine [non-derivatized] (C3DC+C4OH), Butyrylcarnitine (C4), Hydroxybutyrylcarnitine [derivatized] (C4OH), Isovalerylcarnitine (C5), Tiglylcarnitine (C5:1), Glutarylcarnitine (C5DC), Hydroxyisovalerylcarnitine (C5OH), Hexanoylcarnitine (C6), Octanoylcarnitine (C8), Decanoylcarnitine (C10), Decenoylcarnitine (C10:1), Decadienoylcarnitine (C10:2), Myristoylcarnitine (C14), Tetradecenoylcarnitine (C14:1), Palmitoylcarnitine (C16), Hydroxypalmitoylcarnitine (C16OH), Stearoylcarnitine (C18), Oleoylcarnitine (C18:1), Hydroxystearoylcarnitine (C18OH) |
| Adrenoleukodystrophy (ALDPT) | C24:0-lysophosphatidylcholine (24:0-LPC), C26:0-lysophosphatidylcholine (26:0-LPC) |
| Amino Acids and SUAC (AAPT) | Adenosine (Ado), Arginine (Arg), Argininosuccinic Acid (ASA), Citrulline (Cit), Creatine (Cre), Deoxyadenosine (dAdo), Guanidinoacetic acid (GUAC), Guanidinoacetate N-methyltransferase (GAMT) Ratio, Leucine (Leu), Methionine (Met), Phenylalanine (Phe), Succinylacetone (SUAC), Tyrosine (Tyr), Total Homocysteine (tHcy), Valine (Val) |
| Biotinidase Deficiency (BIOTPT) | Biotinidase (BIOT) |
| Cystic Fibrosis DNA Variant Detection (CFDNA) | Cystic Fibrosis DNA Variants |
| Galactose-1-phosphate Uridyltransferase Deficiency (GALTPT) | Galactose-1-phosphate Uridyltransferase (GALT) |
| Glucose-6-phosphate Dehydrogenase Deficiency (G6PDPT) | Glucose-6-phosphate Dehydrogenase (G6PD) |
| anti-HIV-1 Antibodies (HIVPT) | anti-HIV-1 Antibodies |
| Hormone + Total Galactose (HORMPT) | Thyroxine (T4), Thyroid Stimulating Hormone (TSH), 17 α-Hydroxyprogesterone (17OHP), and Total Galactose (TGal) |
| Immunoreactive Trypsinogen (IRTPT) | Immunoreactive Trypsinogen (IRT) |
| Lysosomal Storage Disorders (LSDPT) | Galactoceramidase (GALC), Acid α-Glucosidase (GAA), α-L-Iduronidase (IDUA), α-Galactosidase (GLA), β-Glucocerebrosidase (GBA), Acid Sphingomyelinase (ASM), Iduronate-2-Sulfatase (I2S) |
| Second-tier Congenital Adrenal Hyperplasia (CAHPT) by LC-MS/MS | 17 α-Hydroxyprogesterone (17OHP), 4-Androstenedione (4AD), Cortisol (Cort), 11-Deoxycortisol (11D), 21-Deoxycortisol (21D) |
| Sickle Cell Disease and Other Hemoglobinopathies (HbPT) | Sickle Cell Disease (SCD) and Other Hemoglobinopathies |
| Spinal Muscular Atrophy (SMAPT) | Survival Motor Neuron 1 (SMN1) Exon 7 |
| T-cell Receptor Excision Circle (TRECPT) | T-cell Receptor Excision Circle (TREC) |
| anti-Toxoplasma Antibodies (TOXOPT) | Toxoplasma gondii IgM Antibodies (TOXO) |
| Duchenne Muscular Dystrophy (DMDPT)′ | Creatine Kinase MM (CK-MM) |
| Psychosine (PSYPT)* | Psychosine (PSY) |
| 2nd Tier Materials (2TMPT)* | GAMT ratio (GUAC/CRE)*1000, Alloisoleucine (A-ILE), Malonylcarnitine (C3DC), Creatine (CRE), Ethylmalonic Acid (EMA), Guanidinoacetic Acid (GUAC), Isoleucine (ILE), Leucine (LEU), C24:0-lysophosphatidylcholine (LPC 24:0), C26:0-lysophosphatidylcholine (LPC 26:0), 2-Methylcitric Acid (2-MCA), Methylmalonic Acid (MMA), Total Homocysteine (tHcy), Valine (VAL) |
Quality Control Program List
| Quality Control Programs | Analyte(s) Included |
|---|---|
| 17 α-Hydroxyprogesterone + Total Galactose (17OHPQC and TGalQC) | 17 α-Hydroxyprogesterone (17OHP) and Total Galactose (T-Gal) |
| Cystic Fibrosis DNA Variant Detection (CFDNAQC)′ | QC specimens collectively contain 35 of the 39 CFTR pathogenic variants included in the Luminex xTAG Cystic Fibrosis 39 kit v2. In addition, one specimen contains a pathogenic variant detected by the Luminex xTAG 60 v2 kit, and two specimens contain a pathogenic variant detectable using a sequencing method. |
| Galactose-1-phosphate Uridyltransferase (GALTQC) | Galactose-1-phosphate Uridyltransferase (GALT) |
| anti-HIV-1 Antibodies (HIVQC) | anti-HIV-1 Antibodies |
| Immunoreactive Trypsinogen (IRTQC) | Immunoreactive Trypsinogen (IRT) |
| Lysosomal Storage Disorders (LSDQC) | Galactoceramidase (GALC), Acid α-Glucosidase (GAA), α-L-Iduronidase (IDUA), α-Galactosidase (GLA), β-Glucocerebrosidase (GBA), Acid Sphingomyelinase (ASM), Iduronate-2-Sulfatase (I2S) |
| Tandem MS 1 (MSMS1QC) | Arginine (ARG), Alanine (ALA), Argininosuccinic acid (ASA), Citrulline (CIT), Creatine (CRE), Creatinine (CRN), Guanidinoacetic Acid (GUAC), Glycine (GLY), Homocysteine (Hcy), Leucine (LEU), Methionine (MET), N-Acetyltyrosine (NAT), Ornithine (ORN), Phenylalanine (PHE), Succinylacetone (SUAC), Tyrosine (TYR), Valine (VAL), C0, C2, C3, C3DC, C3DC+C4OH, C4, C4OH, C5, C5:1, C5DC, C5OH, C6, C8, C10, C12, C14, C14:1, C16, C16OH, C18, C18OH, C20-LPC, C22-LPC, C24-LPC, C26-LPC, Adenosine (ADO), Deoxyadenosine (dADO) |
| Thyroxine (T4QC) | Thyroxine (T4) |
| Thyroid-Stimulating Hormone (TSHQC) | Thyroid Stimulating Hormone (TSH) |
| Duchenne Muscular Dystrophy (DMDQC)′ | Creatine Kinase MM (CK-MM) |
| Spinal Muscular Atrophy - T-cell Receptor Excision Circle (SMA-TRECQC)′ | Survival Motor Neuron 1 (SMA) Exon 7, T-cell Receptor Excision Circle (TREC) |
Second-Tier Quality Control Programs
Two events per year
| Second-Tier QC Programs | Analyte(s) Included |
|---|---|
| Second-tier Congenital Adrenal Hyperplasia by LC-MS/MS (CAHQC) | 17 α-Hydroxyprogesterone (17OHP), 4-Androstenedione (2AD), Cortisol (Cort), 11-Deoxycortisol (11D), 21-Deoxycortisol (21D) |
| Psychosine (PSYQC)* | Psychosine (PSY) |
| Second-tier Tier Materials (2TMQC)* | GAMT ratio (GUAC/CRE)*1000, Alloisoleucine (A-ILE), Malonylcarnitine (C3DC), Hydroxybutyrylcarnitine (C4OH), Creatine (CRE), Creatinine (CRN), Ethylmalonic Acid (EMA), Guanidinoacetic Acid (GUAC), Isoleucine (ILE), Leucine (LEU), C20:0-lysophosphatidylcholine (20:0-LPC), C22:0-lysophosphatidylcholine (22:0-LPC), C24:0-lysophosphatidylcholine (24:0-LPC), C26:0-lysophosphatidylcholine (26:0-LPC), 2-Methylcitric Acid (2MA), Methylmalonic Acid (MMA), Total Homocysteine (tHcy), Valine (VAL) |
*New Program(s) Available for Domestic and International Laboratories in Q1 2026
'New Program(s) Available for Domestic Laboratories in Q1 2026